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Summary
The pleiotropic immunoregulatory cytokine transforming growth factor # (TGF-,l3) potently
suppresses production of the human immunodeficiency virus (HIV), the causative agent of the
acquired immunodeficiency syndrome, in the chronically infected promonocytic cell line U1 .
TGF-O significantly (50-90%) inhibited HIV reverse transcriptase production and synthesis of
viral proteins in U1 cells stimulated with phorbol myristate acetate (PMA) or interleukin 6 (IIr6) .
Furthermore, TGF-IQ suppressed PMA induction ofHIV transcription in U1 cells . In contrast,
TGF-O did not significantly affect the expression of HIV induced by tumor necrosis factor ct
(TNF-ci) . These suppressive effects were not mediated via the induction of interferon a (IFN-tx) .
TGF-0 also suppressed HIV replication in primary monocyte-derived macrophages infected in
vitro, both in the absence of exogenous cytokines and in IL6-stimulated cultures. In contrast,
no significant effects of TGF-i8 were observed in either a chronically infected T cell line (ACH-2)
or in primary T cell blasts infected in vitro. Therefore, TGF-a may play a potentially important
role as a negative regulator ofHIV expression in infected monocytes or tissue macrophages in
infected individuals .
number of cytokines, including TNF-ci or -fl, 11,2, IL6
.L IL and granulocyte/macrophage colony-stimulating factor
(GM-CSF),' can upregulate the in vitro expression ofhuman
immunodeficiency virus (HIV) in infected cells (1-4) . Fur-
thermore, increased plasma and/or cerebrospinal fluid levels
of both TNF-tx (5, 6) and IL6 (7, 8) have been reported in
HIVinfected individuals, suggesting that these cytokines could
modulate virus expression in vivo . In contrast, with the ex-
ception of IFNs (3, 9-12), no cytokines have been reported
thus far to exert suppressive effects on HIV expression or repli-
cation .
Transforming growth factor a (TGF-a) is a pleiotropic
cytokine well known as a bifunctional regulator ofthe pheno-
type and proliferative capacity of certain cell lines (13) . It is
secreted in a latent form by a variety of cells (13), including
activated lymphocytes (14) and monocyte/macrophages (15,
16) . Active TGF-a is a chemotactic factor for monocytes (17),
and is a potent suppressive cytokine on T (18) and B (19)
lymphocyte proliferation, NK cell activity (20), macrophage
'Abbreviations used in this paper . Ab, antibody; GM, granulocyte/macro-
phage ; MDM, monocyte-derived macrophages; RT, reverse transcriptase;
TGF-f , transforming growth factor (3.
activation (21), and generation of specific cytotoxic T cells
(22) . Furthermore, TGF-,3 modulates the synthesis and/or
the effects of several other rytokines, such as IM (18, 23),
IL2 (14), IL3 (24), GM-CSF (24), IFN --y (25), and TNF
(23, 25, 26) . Therefore, we investigated whether TGF-/3 could
also affect the induction by certain rytokines of the expres-
sion and/or replication ofHIV in cell lines as well as primary
cell cultures of both T lymphocytic and monocytec lineages .
We have previously established chronically infected cell lines
of promonocytic (4, 27) and T lymphocytic (28) origin .
Among several infected promonocytic clones, the U1 cell line
was further characterized. U1 constitutively expresses low
to undetectable levels ofHIV which can be potently induced
by various agents, including PMA (4, 10, 27), bacterial en-
dotoxin (LPS) (29), and certain cytokines such as GM-CSF
(4, 29), TNF-tx (30, 31), andIM (32) . Similarly, HIV produc-
tion in the chronically infected T cell line ACH-2 is induc-
ible over its low constitutive levels by PMA and TNF-a//3
(10, 28, 33) . In the present study, we demonstrated that the
cytokine TGF-/3 is a suppressor of HIV expression in both
chronically infected promonocytic cells as well as in primary
monocyte-derived macrophages (MDM) . These observations
further support the hypothesis that normal homeostatic mech-
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589-597anisms, which physiologically regulate the immune system,
also play a role as modulators of HIV expression .
Materials and Methods
Induction ofHIVExpression in Chronically Infected Cell Lines.
￿
The
promonocytic cell line Ul and the T lymphocycytec cell lineACH-2
were derived from cells surviving the acuteHIV -1 infection ofU937
(27) andA3.01(28) cells, respectively. Both cell lines are character-
ized by alowcopy number (1-2) ofintegrated proviruses, lowcon-
stitutive expression of HIV, which can be upregulated by PMA
(10, 27, 28), and certain cytokines . ACH-2-derived HIV is infec-
tiousby standardcriteria (passage ofACH-2supernatant onto PHA-
stimulated PBMC (34), whereas Ul-derived HIVhasbeen found
infectious with reduced efficiency exclusively for certain cell lines
(35) . The U937-derived chronically infected clone U33.3, which
is characterized by detectable constitutive production ofHIVand
inducibility byPMAandcytokines (27, 31), was also used in some
experiments. Typically, U1, ACH-2, or U33.3 cells were resuspended
at 2.5 x 10 5 cells/ml in RPMI 1640 (Whitaker M.A . Bio-
products, Walkersville, MD) containing 10% FCS, plated in 96-
well plates (Costar, Cambridge, MA), and stimulated with PMA
(10 - '), rTNF-a (100 U/ml) (Genzyme, Boston, MA), rlL6 (50-
100 U/ml) (Amgen Biologicals, Thousand Oaks, CA),rGM-CSF
(100 U/ml) (Genzyme), or synergistic combinations of these
cytokines (32) in the presence or absence of different concentra-
tions ofpurified TGF-01 (kindly provided by Dr.M.B. Spore, NCI,
NIH), or rTGF-01 (R&D Systems, Minneapolis, MN) at 37°C
in 5% CO2 for 72 h. In some experiments, Ul cells were also
stimulated in the presence of rIFN-a (the generous gift of Dr. S.
Petska, UMDNJ, Robert Wood Johnson Medical School, Pis-
cataway, NJ) either alone or in combination with TGF-/3 . Super-
natants were harvested at different times after stimulation, and tested
for the presence of Mgt*-dependent HIV reverse transcriptase
(RT) activity.
HIV Infection of Primary MDM.
￿
Monocytes obtained from
Ficoll-Hypaque-separated PBMC of seronegative donors were
resuspended in RPMI 1640 containing 10% FCS and purified by
overnight adherence to 24-well tissue culture plates (Costar) resulting
in -106 monocytes/ml/well . Nonadherent cells (predominantlyT
lymphocytes) were eliminated by vigorous washing and pipetting.
Monocyteswere maintained 5-7dbefore infection in IMDM (Gibco
Laboratories, Grand Island,NY)containing 10%FCS, as described
(32) . Then, MDM were infected with a 1:100 dilution of a
macrophage-tropic strain ofHIV (the undiluted viral stock ofAD-
'87, also referred to as ADA 1121), contains -104 infectious
units/ml). Part oftheMDMcultures were stimulated 12-16d after
infection with medium containing cytokines, such as IL6 (100
U/ml), GM-CSF (100 U/ml), andTNF-a (100 U/ml), which we
have previously shown to upregulateHIV replication in these cells
(32) ; TGF-0 (1 ng/ml) ; or combinations of various cytokines and
TGF-/3 . Approximately 50% of the culture supernatants was
replaced with medium or medium containing cytokines every 5 d
for several weeks of culture, and supernatants were collected and
tested for the presence ofRT activity. No gross differences in terms
of cell number and viabilitywere observed in the different condi-
tions used .
RTActivity Assay.
￿
5 itl ofsupernatants was added in duplicate
to 25 ul of a mixture containing poly(A), oligo(dT) (Pharmacia
Fine Chemicals, Piscataway, NJ), MgC12, and 52p-labeled deoxy-
thymidine 5'-triphosphate (dTTP) (Amersham Corp., Arlington
Heights, IL), and incubated for 2 h at 37°C . 6 Al of the mixture
was spotted onto DE81 paper, air dried, washed five times in 2x
SSC buffer, and two additional times in 95% ethanol, as previ-
ously described (36) . The paper was then dried, cut, andcounted
on a scintillation counter (LS 5000 ; Beckman Instruments, Inc.,
Fullerton, CA). Variability ofreplicate cultures was always<15% .
Western Blot Analysis ofHIVProteins .
￿
Cell lysates were prepared
from Ul cells either unstimulated or stimulated for 40hwithPMA
(10-'M) in the presence or absence of TGF-0 (0.5 ng/ml). 20 pl
from the lysate of 10' cells was added to each lane and subjected
to electrophoresis through 10-20% gradient polyacrylamide gels
(Integrated Sep. Sci., Hyde Park, MA) for6 h . The migrated pro-
teins were then transferred overnight onto nitrocellulose filters. After
saturation with a 5% milk solution, filters were incubated for 2 h
with a 1:1,000 (vol/vol) dilution of an AIDS patient serum con-
taining high titers of anti-HIV antibody (Ab) recognizing most
of the major viral proteins (10) . Filters were then washed and in-
cubated for 90 min with "II-labeled protein A (200,000 dpm/ml),
washed, air dried, and exposed overnight to X-ray film.
Northern Blot Analysis ofSteady State HIV RNA.
￿
Total RNA
was extracted from 108 U1 cells by the guanidine thiocyanate
phenol method with an RNA isolation kit (Stratagene, La Jolla,
CA) after 24 h stimulation with PMA in the presence or absence
of TGF-0 (1 ng/ml) . 10 Ag of totalRNA was loaded per lane on
a0.8% agarose formaldehyde gel and transferred to nitrocellulose
filters. The filters were baked and hybridized for 12 h with a
12P-labeled HIVLTR (HindIII-Aval) probe. Filters were washed
and exposed to X-ray film . The labeled probe was removed from
the filters by washing at 80°C in0.1x SSCcontaining 0.1% SDS .
The filters were then rehybridized with a "P-labeled ,82-micro-
globulin cDNA probe.
NuclearRun-on Analysis ofHIV Transcription .
￿
Nuclei from 5 x
10' U1 cells were isolated 17h afterPMA stimulation in the pres-
ence or absenceofTGF-0 (1 ng/ml), and nuclear run-on analysis
wasperformedaccording to apublishedmethod (37) . Briefly, equal
amounts of 32P-labeledRNAwere hybridized to linearized plasmid
DNAprobes (includingPUC 19, as plasmid control, pNL4-3, con-
taining a full-length HIV genome [381) and a human 02-micro-
globulincDNA,immobilized on nitrocellulose filters, whichwere
then exposed to X-ray film .
Results
TGR0 Suppresses PMA-inducedExpression ofHIV .
￿
U1 and
ACH-2 cellswere first stimulated with PMA in the presence
or absence of different concentrations (0.04-5 ng/ml) of TGF-(3,
andculture supernatants were tested for the presence ofHIV
RT activity. No detectable effects were observed in U1 cells
stimulated with TGF-0 alone; however, UI cells stimulated
with PMA in the presence ofTGF-0 showed a significantly
reducedproduction ofHIV (Fig . 1 A) . No significant differ-
ences were observed when U1 cells were preincubated with
TGF-0 for up to 4 h before the addition of PMA as com-
paredwith cells simultaneously treated with the two agents .
Suppression of virus expression by TGF-0 was observed
throughout a 7-d culture period, and it was not attributable
to cytotoxicity or decreased cell proliferation, as determined
by trypan blue dye exclusion and [3H]thymidine incorpora-
tion analysis, respectively. TGF-0inhibition ofRT produc-
tion was correlated with a significant reduction ofviral pro-
tein synthesis, as demonstrated by Western blot analysis
performed on U1 cell lysates (data not shown), and with a
significant reduction in the accumulation ofboth splicedand
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TGF-/3 suppression of PMA-stimulated HIV expression in
Ul cells. (A) Suppression ofRT production byTGF-fl . Comparableeffects
were observed throughout a 7-d culture period after a single treatment
with PMA and TGF-/3 . Results are representative of five independent ex-
periments. (B) TGF-Oinhibition ofsteady state HIVRNA accumulation.
The results shown were obtained by Northern blot hybridization oftotal
RNA extracted from U1 cells after 24-h stimulation. No significant differ-
ences were observed when RNA was extracted at different time points
up to 48 h post-stimulation . Comparable amounts ofRNA were loaded
onto each lane, as established by reprobing the filters with a S2-micro-
globulin cDNA (data not shown) .
unspliced mRNA species (Fig. 1 B) . Furthermore, a potent
inhibition ofPMAinduced HIV transcription byTGF-O treat-
ment ofU1 cells was demonstrated by nuclear run-on anal-
ysis (Fig. 2) . These findings indicated that TGF-0 interfered
with earlier steps of virus expression in these chronically in-
fected cells as compared with the post-translational block of
HIV production previously described for IFN-a (10) . In con-
trast to the findings with U1 cells, TGF-(3 showed no in-
hibitory effect on PMA-induced HIV expression in the
chronically infected T lymphocytic cell lines, ACH-2 (data
not shown) .
Lack ofTGF--0 Effect on TNF-a-induced Expression ofHIV .
A similar degree of suppression by TGF-/3 was observed in
U1 cells stimulated with a crude cytokine-enriched superna-
tant obtained from primary monocytes stimulated in vitro
with LPS. In this regard, we have previously demonstrated
that TNF-a is one of the major HIVinductive monokines
secreted by LPS-stimulated monocytes (28) . Therefore, we
investigated the ability ofTGF-0 to suppress HIV produc-
tion in U1 cells stimulated with rTNF-a . However, in con-
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Figure 2 .
￿
TGF-0 suppression of PMA-induced HIV transcription . (A)
Nuclear run-on analysis was performed on nuclei extracted from U1 cells
stimulated for 17 h with PMA (10- 7 M) in the presence or absence of
TGF-O (1 ng/ml) . The transcriptional inhibitor a-amanitin almost en-
tirely inhibitedtranscription in Ui cells. (B) Densitometric laser scanning
ofthe levels of newly synthesized HIV mRNA . Filters of the run-on ex-
periments shown inA were subjected tolaser scanning densitometric analysis
(2222-10;LKB Instruments, Ire., Gaithersburg, MD) . Theresults are shown
as ratios of the areas under the curve of the scanned HIV RNA bands
normalized to those ofthe 02-microglobuhn controls, giving the arbitrary
value of 1 to the ratio measured in unstimulated conditions. Similar results
were obtained when fl-actin was used as control .
trast to the inhibitory effects observed in U1 cells stimulated
withPMA or LPS-monocyte supernatant, TGF-fl had no sup-
pressive effects on the induction ofHIV expression by TNF-a,
as measured byRT activity (Fig. 3A) and Western blot anal-
ysis ofcell-associated viral proteins . Furthermore, TGF-0 did
not inhibit either steady state accumulation or transcription
ofHIV RNA in U1 cells stimulated with TNF-a (data not
shown) . TGF-0 inhibition ofPMAinduced, but notTNF-a-
induced, virus production was confirmed in a second (U33.3)
chronically infected promonocytic cell line .
TGIZ# Does NotAffect the PMA-induced TNF-ci Autocrine
Pathwy in UI Cells. We have previously reported that part
of the inductive effect ofPMA on U1 cells is accounted for
by the triggering ofan autocrine pathway ofHIV expression
mediated by the synthesis and release of endogenous TNF-a
(31) . Asshown in Fig. 3A, antiTNF-a-neutralizingAb par-Figure 3 .
￿
TGF-0 does not affect either theHIVinductive effect of ex-
ogenous TNF-a or the secretion ofendogenous TNF-a in U1 cells stimu-
lated withPMA . (A) TGF-0 does not suppress TNF-a induction ofHIV
expression . U1 cells were stimulated with either 100 U/ml of rTNF-a
or 10-7MPM in the presence or absence of a 1:100 (vol/vol) dilution
of a neutralizing antiTNF-a Ab (31), control Ab, or TGF-0 (1 ng/ml) .
Supernatants were collected after 72 h and tested for RT activity. The
results shown arerepresentative offive independent experiments. (B) TGF-0
suppresses expression ofHIV, but not secretionofTNF-a in UI cells stimu-
lated withPMA. U1 cells were stimulated with 10-7M PMA in the pres-
ence or absence ofTGF-0 (1 ng/ml) ; supernatants were collected at different
times and tested forRT activity. In parallel, supernatants were also tested
for the presence ofTNF-a by a commercially available ELISA kit (T Cell
Sciences, Inc., Cambridge, MA) . No significant levels ofRT activity or
TNF-cY secretion were detected in unstimulatedconditions. (C) Coopera-
tive suppression of PMA-induced expression ofHIV in U1 cells byTGF-0
and antiTNF-aAb. U1 cells were briefly (2 h) pretreated with 20 nU/ml
of antiTNF-ac mAb (Olympus, Lake Success, NJ), TGF-0 (0.4 ng/ml),
or both antiTNP-a mAb and TGF-0 before stimulation with 10-1 M
PM. Supernatants were harvested and tested for RT activity 72 h after
stimulation .
tially blockedPMAinducedHIV expression inU1 cells. There-
fore, we investigated whether TGF-0 could affect the ability
ofPMA to induce TNF-ci production in U1 cells . However,
as previously observed in uninfectedPBMC stimulated with
Figure 4 .
￿
TGF-0 suppresses IL6 induction of HIV expression in U1
cells . (A) TGF-S suppresses HIV production in U1 cells stimulated with
11,6 . Cells were stimulated with 50 U/ml of IL6 in the presence or ab-
sence of TGF-0 (0.5 ng/ml), or 1:100 dilution of anti-IL6 mAb (R &
D Systems, Minneapolis, MN) . Supernatants were collected throughout
7 d of culture and were tested for the presence ofRT activity. (B) TGF-S
blocks the induction of HIV protein expression in U1 cells stimulated
with IL6 . Western blot analysis was performed on cell lysates of U1 cells
either unstimulated or stimulated for 40 h with 10-7M PMA in the pres-
ence or absenceof TGF-0 . (C) TGF-0 suppresses the synergistic induction
of HIV expression in UI cells costimulated with TNF-a (10 U/ml) and
various concentrations ofIIr6 . Similar results were obtained when higher
(100 U/ml) concentrations of TNF-a and IL6 were used, and were also
observed in U1 cells synergistically stimulated with TNF-ci andGM-CSR
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or the amount ofTNF-c i produced by Ul cells under these
conditions (Fig. 3 B) . Furthermore, TGF-0 did not alter the
number or the affinity ofTNF receptors in PMA-stimulated
cells (data not shown) . Thus, TGF-f3 seems capable of sup-
pressingPMAinducedHIV expression by a different mecha-
nism other than the TNF-cx autocrine pathway triggered in
Ul cells by the phorbol ester. In support of this hypothesis,
a virtually complete inhibition ofHIV production (in the
absence oftoxicity) was observed when Ul cells were stimu-
lated with PMA in the presence of both TGF-fl and anti-
TNF-a Ab (Fig . 3 C) .
TCF--0 Suppresses IL6-induced Expression of HIV in U1
Cells. These findings suggested that HIVinductive factors
other than TNF-a were blocked by TGF-f3 when Ul cells
were stimulated with crude cytokine preparations . In this re-
gard, we have observed recently that IL6, a cytokine induced
by LPS stimulation of monocyte/macrophages (39), upregu-
lates virus expression in Ul andU33.3 cells (32) . In contrast
to TNF-a, which upregulates virus production by activa-
tion of the cellular transcription factor NF-kB (40-42), IL6
induces HIV expression in these cell lines predominantly by
acting at a post-transcriptional level (32) . Therefore, we next
investigated whether TGF-f3 could suppress the induction of
HIV expression triggered by 11,6 . As shown in Fig. 4 A,
TGF-f3 completely suppressed the production ofvirus in U1
cells stimulated with IL6, and this effect was also correlated
with a reduction ofviral protein synthesis to virtually unde-
tectable levels (Fig. 4 B) . Furthermore, TGF-f3 completely
blocked both RT production and synthesis ofHIV proteins
inU1 cells stimulated withGM-CSF, which, similar to 11,6,
affects predominantly a post-transcriptional step ofHIV ex-
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Figure 5.
￿
Suppression of PMA-induced HIV ocpression in Ul cells treated
with TGF-Q and IFN-a . A virtually complete inhibition of virus produc-
tion was observed in Ul cells stimulated with PMA in the presence of
TGF-0 and IFN-at, whereas treatment with individual cytokines led only
to a partial, although significant suppression. Additive antiviral effects were
observed in PMA-stimulated Ul cells treated with suboptimal concentra-
tions of TGF-0 and IFN-cr .
pression in these cells (G. Poli, A . L . Kinter, J . S. Justement,
and A . S. Fauci, unpublished observations) .
We have also reported that TNF-a synergizes with either
IL6 or GM-CSF in the induction ofHIV expression in U1
cells (32) . TGF-fl significantly inhibited the production of
HIV in U1 cells costimulated with TNF-ci and 11,6 (Fig .
4 C), or TNFLot andGM-CSF (not shown), and these findings
were confirmed by Western blot analysis . Thus, TGF-f3 can
suppress the expression ofHIV by interfering with both tran-
scriptional (in cells stimulated with PMA), and post-tran-
scriptional (in cells stimulated with IL6, GM-CSF, or costimu-
lated with both cytokines) pathways of virus activation . No
significant differences between the two isoforms of TGF-f3
(TGF-f31 and -f32) (reviewed in reference 13) were observed
in terms of their suppressive effects on U1 cells stimulated
with various inducers ; furthermore, antiTGF-f3 Ab neutral-
ized the suppressive abilities of TGF-f3 on HIV expression .
Since neither IL6 nor GM-CSF induce expression of HIV
and ACH-2 cells, the effects of TGF-# on this system were
not studied .
Cooperative Suppressive Effects ofTGF-0 and IFN-a on the
Induction ofHIVExpression in UI Cells. We have previously
reported that IFN-a exerts a potent suppressive effect on HIV
production in chronically infected U1 andACH-2 cells (10) .
As described in cells chronically infected with murine ret-
roviruses (43-45), IFN-a blocked the release ofmature virions
from the plasmamembrane ofUl and ACH-2 cells, without
suppressing HIV protein synthesis (10) . WhenU1 cells were
stimulated with PMA in the presence ofTGF-O and various
concentrations of IFN-a, a virtually complete suppression
of virus production was observed in the culture supernatant
(Fig . 5) . Similar results were obtained when U1 cells were
stimulated with 1176 (data not shown) .
Thus, TGF-f3 and IFN-a affect different steps of the HIV
life cycle in chronically infected U1 cells (such as transcrip-
tion and translation of viral RNA vs. budding of morpho-
logically mature viral particles from the plasma membrane,
respectively) . Nonetheless, we investigated whether the sup-
pressive effect ofTGF-0 could be accounted for by endoge-
nous production ofIFN-a or -f3 . No detectable IFN-a pro-
duction, as determined by vescicular stomatitis virus yield
reduction assay (43-45), was observed in the different stimula-
tory conditions described above (P. M . Pitha, G. Poli, and
A : S . Fauci, unpublished observations) . Furthermore, anti-
IFN-a Ab, which reversed the inhibitory effect ofIFN-a on
U1 cells, did not significantly affect TGF-f3 suppression of
HIV expression (data not shown) .
TGIRO Suppresses HIVReplication in PrimaryMDM .
￿
We
further investigated whether TGF-f3 could also suppress HIV
infection of primary cultures ofMDM. In this regard, we
have previously demonstrated that IL6, as well as GM-CSF
and TNF-a, significantly upregulates both the kinetics and
the extent of replication of a macrophage tropic HIV strain
in primaryMDM (32) . Consistent with our observations with
chronically infected promonocytic cell lines, TGF-# also in-
hibited HIV replication inMDM. InMDM cultures estab-
lished from certain individuals, virus production was clearly
detectable in unstimulated conditions, and was significantlyDays Post-Infection
O Uninfected
O Unstimulated
0 IL-6 (lfb U/mq
TGF-p (1 nyfmq
IL-6 + TGF-p
B
Figure 6.
￿
TGF- i6 inhibition of HIV replication during acute infection
of primaryMDM. As shown in A, some MDM cultures showed detect-
able levels ofRT production even when maintained with medium in the
absence of IIr6 (unstimulated) . TGF-0 suppressed both the constitutive
(A) and the IIr6-induced (A and B) levels of HIV replication in MDM .
The results are representative of six independent experiments .
enhanced by IL6 (Fig. 6 A), whereas in cells obtained from
other donors, significant levels of virus replication were ob-
served only in the presence of IL6 (Fig. 6 B) . The different
patterns ofHIV replication observed in these cultures could
not be accounted for by increased levels of cytopathicity or
gross differences in the numbers of MDM, but probably
reflected a significant variability among different individuals
in terms of the activation state of their circulating mono-
cytes and/or susceptibility of these cells to HIV infection,
as previously observed for T lymphocytes (46) . Nonetheless,
TGF-0 suppressed both the constitutive as well as the IIr6-
stimulated production of virus (Fig. 6, A and B) in the ab-
sence of cytotoxicity or evident effects on cell adherence . Simi-
larly, TGF-0 suppressed HIV replication inMDM cultures
stimulated withGM-CSF, whereas variable results (either sup-
pression or no effect) were obtained in TNF-a-treated cul-
tures (data not shown) . Spreading ofHIV in primaryMDM
is correlated with the accumulation of infectious virus parti-
cles and RT activity in the culture supernatants. In contrast
to other retrovi;al proteins, such as gag and envelope, which
can be shed by infected cells in culture supernatants, RT en-
zymatic activity is exclusively associated with released viral
particles both in HIV (47, 48) and other animal retroviruses
(49, 50) . We have recently confirmed this finding in our HIV
infected monocytic cell systems (Fernie, B. F., G. Poli, and
A . S. Fauci, manuscript in preparation) . Therefore, inhibi-
tion of the accumulation ofRT activity by TGF-0 observed
in our primaryMDM cultures (Fig. 6) directly reflects a re-
duced production of infectious HIV In contrast, as previ-
ously observed with the chronically infected T cell lineACH-2,
TGF-a did not significantly affect either the kinetics or the
levels ofHIV replication in mitogen-stimulated T cell blasts
infected with aT lymphocytotropic strain ofHIV (LAV) (data
not shown) .
Discussion
In the present study, we have demonstrated that the im-
munoregulatory cytokine TGF-0 suppresses both virus ex-
pression in chronically infected cell lines of the monocyte/
macrophage lineage and HIV replication in acutely infected
primaryMDM . In chronically infected cells, TGF-0 affects
earlier steps of the virus life cycle (such as transcription and
accumulation of HIV mRNA as well as synthesis of viral
proteins in the case of PMA induction of HIV) than those
inhibited by IFN-cx, which blocks the production of virions
at a post-assembly level (10) . TGF-a also suppresses the in-
ductive ability ofcertain cytokines (I1r6 and GM-CSF), which
alone or in synergistic combination upregulate synthesis of
viral proteins and virus production predominantly at a post-
transcriptional level (32) . Furthermore, TGF-0 is also effec-
tive in blocking the cooperation between these cytokines and
TNF-a, which ofitself is not affected by TGF-0 . Although
it is difficult to determine whether TGF-0 reduces spread of
infectious virus in chronically infected Ul cells, since every
cell in culture already has two integrated copies of HIV
provirus, TGF-0 did potently block the production of infec-
tious virus in primaryMDM acutely infected with a macro-
phage tropic strain of HIV Of note is the fact that others
have recently reported that TGF-0 upregulated HIV expres-
sion in a system of acute infection ofMDM (51) . Although
TGF-0 consistently downregulated HIV replication in our
MDM cultures, we did observe a similar enhancing effect
of TGF-0 on the acute infection of U937 cells, which are
the uninfected parental cells of Ul (G . Poli, A. L . Kinter,
S . J . Justement, and A . S. Fauci, unpublished observations) .
Thus, under certain experimental conditions, bifunctional
effects ofTGF-0 can be seen on HIV expression similar to
the bifunctional effects ofthis molecules on other cell systems
(reviewed in reference 13) . The precise mechanisms involved
in this dichotomy of effects are unclear at present .
Because both TNF-ca (40-42) and PMA (52, 53) have been
reported to induce expression of HIV via activation of the
cellular transcription factor NF-M the lack ofTGF-0 effect
on TNF-cx-stimulated cells suggests that the NF-kB-mediated
pathway is not significantly affectedby TGF-0, and that TGF-0
suppression ofPMAinduced HIV expression may be medi-
ated by mechanisms not directly related to NF-kB. In sup-
port of this hypothesis, TGF-0 did not inhibit either PMA
or TNF-cx induction of the HIV long terminal repeat (LTR),
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tivity in the U1 uninfected parental cell lineU937 transfected
with an HIVLTRCAT construct (G . Poli, A . L . Kinter, P .
Bressler, and A . S . Fauci, unpublished observations) . Alter-
natively, PMA and TNF-o : may trigger different pathways
ofNF-kB activation inU1 cells, as recently described in unin-
fected K562 andjurkat cells (54) . Further studies are in prog-
ress in our laboratory to address these hypotheses .
We further investigated whether the suppressive effect of
TGF-(3 onHIV infection inU1 cells was correlated with the
induction of endogenous IFN-cx (or -a), which would sup-
press the expression of virus. This possibility was supported
by previous observations that anti-IFN-ci-neutralizing Ab
could upregulate the replicative capacity ofHIV in bothU937
cells (55) as well as in mitogen-stimulatedPBMC (56) . How-
ever, no evidence ofIFN-ci/o production or effect was found
in U1 cells, regardless ofthe presence ofTGF-(3 . In addition,
the combination ofTGF-0 and IFN-ot resulted in the virtu-
ally complete suppression of HIV production in U1 cells,
References
further indicating that these two cytokines affected different
steps of HIV expression .
Of note is the fact that it has been recently reported that
PBMC from HIV-infected individuals show an increased in
vitro production ofTGF-0 (57) . The present study suggests
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